Related Experiment Video
Updated: Jun 28, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice
Anne T Funding1, Claus Johansen, Matthias Gaestel
1Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Abstract:
Mitogen-activated protein kinase (MAPK) AP kinase 2 (MK2) is a serine/threonine kinase that is phosphorylated and activated by p38 MAPK. MK2 regulates the expression of various proinflammatory cytokines including TNF-alpha, IL-1beta, IL-6, and IL-8. Recently, MK2 was demonstrated to be activated in lesional psoriatic epidermis. This study investigates for the first time the role of MK2 in skin inflammation using the model of oxazolone-induced acute allergic contact dermatitis in mice. We show that oxazolone treatment leads to increased expression and sustained activation of both p38 MAPK and MK2. The inflammatory response was determined by ear thickness, myeloperoxidase activity, and histology after oxazolone challenge. Pretreatment with the p38 MAPK inhibitor SB202190 and genetic ablation of MK2 inhibit this inflammatory response. In particular, IL-1beta and, to a smaller but significant extent, also TNF-alpha and IFN-gamma expression were decreased in MK2 knockout mice compared with wild-type mice. These results indicate that MK2 is a potential target for the treatment of inflammatory skin diseases.
Insights
Mitogen-activated protein kinase 2 (MK2) plays a key role in skin inflammation. Inhibiting MK2 or its upstream activator p38 MAPK reduces inflammatory responses in a mouse model of allergic contact dermatitis.
Area of Science:
- Immunology
- Dermatology
- Molecular Biology
Background:
- Mitogen-activated protein kinase (MAPK) activated protein kinase 2 (MK2) is activated by p38 MAPK.
- MK2 regulates proinflammatory cytokines, and its activation is observed in psoriatic epidermis.
- The role of MK2 in skin inflammation is not well understood.
Purpose of the Study:
- To investigate the role of MK2 in skin inflammation.
- To examine MK2 activation in oxazolone-induced acute allergic contact dermatitis (ACD) in mice.
Main Methods:
- Mice were sensitized and challenged with oxazolone to induce ACD.
- Expression and activation of p38 MAPK and MK2 were analyzed.
- Inflammatory response was assessed by ear thickness, myeloperoxidase activity, and histology.
- The effect of p38 MAPK inhibitor SB202190 and MK2 knockout (KO) was evaluated.
Main Results:
- Oxazolone treatment increased p38 MAPK and MK2 expression and activation.
- SB202190 and MK2 deficiency significantly inhibited the inflammatory response.
- MK2 KO mice showed decreased expression of IL-1beta, TNF-alpha, and IFN-gamma compared to wild-type mice.
Conclusions:
- MK2 is activated during acute allergic contact dermatitis.
- MK2 is a critical mediator of skin inflammation.
- MK2 represents a potential therapeutic target for inflammatory skin diseases.